title: Targeting cerebrovascular impairments in Huntington's disease: a novel treatment perspective.
authors.affiliation: Centre de Recherche du CHU de Québec (CHUQ), Québec, QC, G1V 4G2, Canada.|Département de Psychiatrie & Neurosciences, Université Laval, Québec, QC, G1V 0A6, Canada.
authors.forename: Isabelle
authors.initials: I
authors.lastname: St-Amour
authors.affiliation: Centre de Recherche du CHU de Québec (CHUQ), Québec, QC, G1V 4G2, Canada.
authors.forename: Benoit
authors.initials: B
authors.lastname: Aubé
authors.affiliation: Centre de Recherche du CHU de Québec (CHUQ), Québec, QC, G1V 4G2, Canada.|Département de Psychiatrie & Neurosciences, Université Laval, Québec, QC, G1V 0A6, Canada.
authors.forename: Marie
authors.initials: M
authors.lastname: Rieux
authors.affiliation: Centre de Recherche du CHU de Québec (CHUQ), Québec, QC, G1V 4G2, Canada.|Département de Psychiatrie & Neurosciences, Université Laval, Québec, QC, G1V 0A6, Canada.
authors.forename: Francesca
authors.initials: F
authors.lastname: Cicchetti
mesh_terms: D000818:Animals; D001812:Blood-Brain Barrier / Q000378:metabolism* / Q000503:physiopathology; D002561:Cerebrovascular Disorders / Q000209:etiology / Q000378:metabolism* / Q000628:therapy*; D006801:Humans; D006816:Huntington Disease / Q000150:complications / Q000378:metabolism*
keywords: angiogenesis; blood–brain barrier; neurodegenerative diseases; neurovascular unit